HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ayumi Shimamura Selected Research

2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acid

3/2024Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ayumi Shimamura Research Topics

Disease

1Non-alcoholic Fatty Liver Disease
03/2024
1Allergic Rhinitis
11/2022

Drug/Important Bio-Agent (IBA)

1saroglitazarIBA
03/2024
1lanifibranorIBA
03/2024
1seladelparIBA
03/2024
1fenofibric acidFDA Link
03/2024
1(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
03/2024
12- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA
03/2024
1Pioglitazone (Actos)FDA Link
03/2024
1BezafibrateIBA
03/2024
1Mediator Complex Subunit 1IBA
03/2024
1LigandsIBA
03/2024
1Peptides (Polypeptides)IBA
03/2024
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2024

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2022